EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tissue MicroRNA Expression Signatures as Diagnostic Biomarkers and Predictors of Residual Disease Activity and Relapse in Treatment-Naïve Pediatric Inflammatory Bowel Disease

Tereza Deissova iD, Dagmar Al Tukmachi iD, Lenka Radova iD, Julia Bohosova iD, Tana Machackova iD, Leos Kren iD, Matej Hrunka iD, Tereza Pinkasova iD, Martina Ambrozova iD, Jiri Sana iD, Ondrej Slaby iD, Petr Jabandziev iD

Inflammatory Bowel Diseases · 01.11.2025 · 31 (11) · 3033-3043

DOI: 10.1093/ibd/izaf120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 26.08.2025. Verfasst von Tereza Deissova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Hauptthemen laut MEDLINE: MicroRNAs, Biomarkers, Colitis, Ulcerative, Crohn Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health of the Czech Republic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identifying novel diagnostic and prognostic biomarkers for pediatric inflammatory bowel diseases (PIBD), including Crohn’s disease (pCD) and ulcerative colitis (pUC), is essential for enhancing treatment outcomes. MicroRNAs (miRNAs) have been recognized for their broader relevance in PIBD pathogenesis. This study investigates their diagnostic potential and clinical utility in PIBD.

Methods

This prospective, monocentric study, with retrospective validation, involved 119 PIBD patients (58 pCD, 61 pUC) and 39 non-IBD controls. Small RNA next-generation sequencing was performed on fresh-frozen gut biopsies, targeting histopathologically confirmed inflamed areas. Twenty-five dysregulated miRNA candidates were validated via RT-qPCR in formalin-fixed, paraffin-embedded gut biopsies. Logistic regression was used to establish diagnostic and prognostic miRNA expression signatures.

Results

A diagnostic signature of 5 miRNAs (miR-223-3p, miR-34a-5p, miR-194-5p, miR-215-5p, miR-338-3p) distinguished pCD from non-IBD with 96.49% accuracy. Two miRNAs (miR-223-3p, miR-194-5p) differentiated pUC from non-IBD with 100% accuracy, and miR-215-5p distinguished pCD from pUC specimens with 83.54% accuracy. For treatment-naïve pCD patients, 7 miRNAs predicted residual disease activity at 3 months with 100% accuracy. Additionally, a distinct signature predicted the risk of relapse within 12 months with an accuracy of 84.21%.

Conclusions

In this study, we have established tissue miRNA expression signatures with significant diagnostic and prognostic potential for use in PIBD. These findings aid in stratifying disease severity and risk, paving the way for more precise and personalized management of pediatric IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBiomarkersColitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesHumansMaleFemaleChildRecurrenceAdolescentProspective StudiesPrognosisRetrospective StudiesCase-Control StudiesChild, PreschoolGene Expression ProfilingFollow-Up Studies

Stichwörter der Autor:innen

inflammatory bowel diseasemicroRNA markerspediatric

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Department of Biochemistry, Faculty of Science, Masaryk University, Brno, Czech Republic.
  • Department of Pathology, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Center for Precision Medicine, University Hospital Brno, Brno, Czech Republic.

ORCID-Profile: Tereza Deissova, Dagmar Al Tukmachi, Lenka Radova, Julia Bohosova, Tana Machackova, Leos Kren, Matej Hrunka, Tereza Pinkasova, Martina Ambrozova, Jiri Sana, Ondrej Slaby, Petr Jabandziev

Förderung

  • Ministry of Health of the Czech Republic

Zitieren

APA

Deissova, T., Al Tukmachi, D., Radova, L., Bohosova, J., Machackova, T., Kren, L., Hrunka, M., Pinkasova, T., Ambrozova, M., Sana, J., Slaby, O., & Jabandziev, P. (2025). Tissue MicroRNA Expression Signatures as Diagnostic Biomarkers and Predictors of Residual Disease Activity and Relapse in Treatment-Naïve Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 31(11), 3033-3043. https://doi.org/10.1093/ibd/izaf120

Vancouver

Deissova T, Al Tukmachi D, Radova L, Bohosova J, Machackova T, Kren L, et al. Tissue MicroRNA Expression Signatures as Diagnostic Biomarkers and Predictors of Residual Disease Activity and Relapse in Treatment-Naïve Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2025;31(11):3033-3043. doi:10.1093/ibd/izaf120

BibTeX
@article{Deissova2025,
  author = {Deissova, Tereza and Al Tukmachi, Dagmar and Radova, Lenka and Bohosova, Julia and Machackova, Tana and Kren, Leos and Hrunka, Matej and Pinkasova, Tereza and Ambrozova, Martina and Sana, Jiri and Slaby, Ondrej and Jabandziev, Petr},
  title = {Tissue MicroRNA Expression Signatures as Diagnostic Biomarkers and Predictors of Residual Disease Activity and Relapse in Treatment-Naïve Pediatric Inflammatory Bowel Disease},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  volume = {31},
  number = {11},
  pages = {3033--3043},
  doi = {10.1093/ibd/izaf120}
}
Kostenlos starten →